Efficacy and Safety Profile of Biosimilar Polyethylene Glycol (PEG)-Asparaginase (Asviia) in Patients With Acute Leukemia: A Retrospective Study From Kashmir
The study provides valuable insights into the efficacy and safety of biosimilar PEG-ASP for pediatric ALL in resource-limited settings, with strong data on remission rates and minimal adverse events.
Authors
- Zafirah Zahir (ORCID: https://orcid.org/0000-0002-6891-7136)
- Ulfat Ara Wani
- Shumail Bashir
- Syed Nisar (ORCID: https://orcid.org/0009-0003-9002-4902)
- Richa Tripathi (ORCID: https://orcid.org/0000-0001-8228-9052)
- Suyash Bharat (ORCID: https://orcid.org/0000-0002-0743-320X)
- Mohmad Hussain Mir
- Rukhsana Akhter
- Faisal R. Guru
Institutions
- Sher-i-Kashmir Institute of Medical Sciences (IN)
- Zydus Lifesciences Limited (India) (IN)
- Barkatullah University (IN)
Publication Details
- Journal
- Cureus
- Published
- 2024-11-15
- DOI
- https://doi.org/10.7759/cureus.73727
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00